Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-29 4:53 pm Purchase | 2024-01-18 | 13G | Viridian Therapeutics, Inc. VRDN | Perceptive Advisors LLC | 4,022,066 6.700% | 4,022,066 (New Position) | Filing History |
| 2024-01-29 3:26 pm Purchase | 2023-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | BlackRock Inc. BLK | 3,426,450 6.500% | 664,894 (+24.08%) | Filing History |
| 2024-01-24 5:12 pm Purchase | 2024-01-22 | 13D | Viridian Therapeutics, Inc. VRDN | Fairmount Funds Management LLC | 13,956,685 19.430% | 1,192,292 (+9.34%) | Filing History |
| 2024-01-24 08:13 am Purchase | 2023-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | STATE STREET CORP STT | 2,708,383 5.150% | 2,708,383 (New Position) | Filing History |
| 2024-01-10 08:53 am Purchase | 2024-01-09 | 13G | Viridian Therapeutics, Inc. VRDN | FMR LLC | 7,625,542 14.501% | 7,625,542 (New Position) | Filing History |
| 2023-12-08 4:17 pm Purchase | 2023-11-01 | 13G | Viridian Therapeutics, Inc. VRDN | Venrock Opportunities Fund L.P. | 2,823,921 5.200% | 2,823,921 (New Position) | Filing History |
| 2023-11-03 4:30 pm Purchase | 2023-10-30 | 13D | Viridian Therapeutics, Inc. VRDN | Fairmount Funds Management LLC | 12,764,393 19.990% | 3,571,579 (+38.85%) | Filing History |
| 2023-06-14 4:15 pm Unchanged | 2023-05-23 | 13D | Viridian Therapeutics, Inc. VRDN | Atlas Venture Fund VII L P | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-05-11 4:26 pm Purchase | 2023-05-01 | 13G | Viridian Therapeutics, Inc. VRDN | Paradigm BioCapital Advisors LP | 2,310,698 5.400% | 419,531 (+22.18%) | Filing History |
| 2023-02-14 4:59 pm Purchase | 2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Paradigm BioCapital Advisors LP | 1,891,167 4.700% | 682,116 (+56.42%) | Filing History |
| 2023-02-14 4:30 pm Purchase | 2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Venrock Healthcare Capital Partners III, L.P. | 4,230,621 9.990% | 2,025,353 (+91.84%) | Filing History |
| 2023-02-14 3:05 pm Sale | 2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Cormorant Asset Management, LP | 1,100,000 2.730% | -336,322 (-23.42%) | Filing History |
| 2023-02-14 2:23 pm Purchase | 2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | TCG Crossover GP I, LLC | 983,610 2.400% | 983,610 (New Position) | Filing History |
| 2023-02-14 11:43 am Purchase | 2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | BIOTECHNOLOGY VALUE FUND L P | 2,302,094 5.600% | 99,779 (+4.53%) | Filing History |
| 2023-02-14 08:59 am Purchase | 2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Deep Track Capital, LP | 3,312,974 7.930% | 1,493,285 (+82.06%) | Filing History |
| 2023-02-13 5:45 pm Purchase | 2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Vivo Opportunity LLC | 1,678,207 4.200% | 378,207 (+29.09%) | Filing History |
| 2023-02-09 11:35 am Purchase | 2022-12-30 | 13G | Viridian Therapeutics, Inc. VRDN | The Vanguard Group | 2,114,994 5.250% | 2,114,994 (New Position) | Filing History |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | BlackRock Inc. BLK | 2,761,556 6.900% | 2,761,556 (New Position) | Filing History |
| 2023-01-26 5:03 pm Sale | 2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Millennium Management LLC | 785,854 2.000% | -636,623 (-44.75%) | Filing History |
| 2022-08-19 4:34 pm Purchase | 2022-08-17 | 13D | Viridian Therapeutics, Inc. VRDN | Fairmount Funds Management LLC | 9,192,814 19.990% | 5,732,463 (+165.66%) | Filing History |